Pinealon vs SS 31
Evidence tier, human-evidence strength, regulatory status, and hype-vs-data — side by side.
On published evidence, SS 31 currently grades higher (C-tier vs F-tier). That reflects evidence maturity, not that it's “better” for any person or goal.
- Stronger human evidence: SS 31
- More hype than data: neither stands out
| pinealon | ss-31 | |
|---|---|---|
| Class | Mitochondrial & longevity peptides | Mitochondrial & longevity peptides |
| Regulatory status | Research-use-only | Research-use-only |
| Candidate sources | 0 | 0 |
| Top study types (candidate) | — | — |
| Translation risk | pending review | pending review |
Pinealon vs SS 31: FAQ
Is Pinealon better than SS 31?
On published evidence, SS 31 currently grades higher (C-tier vs F-tier). That reflects evidence maturity, not that it's “better” for any person or goal. Neither is a recommendation to use anything; this compares the state of the evidence only.
What's the difference between Pinealon and SS 31?
Pinealon is research-use-only and sits at the “Anecdote” evidence stage; SS 31 is research-use-only and sits at “Early human.”
Which has stronger human evidence, Pinealon or SS 31?
SS 31 has the stronger human-evidence signal of the two on our scale.
Research reference only. Not medical advice, treatment instructions, or a purchase recommendation. Consult a licensed professional.